Award presented during the 2025 SCRS Global Site Solutions Summit Eagle Award Gala.
On September 30, 2025, the Society for Clinical Research Sites (SCRS), announced that Medpace has been recognized as the CRO 2025 SCRS Eagle award recipient.
Medpace is honored to announce that we have been awarded the SCRS 2025 CRO Eagle Award. Since 2009, the SCRS Eagle Award has recognized one CRO and Sponsor each year who embody the importance of building trusted partnerships with clinical research sites to drive development forward.
This year, nearly 2,000 research sites from across the globe participated in the annual SCRS Eagle Award survey to evaluate sponsor and CRO partners who consistently demonstrate excellence across multiple operational areas based on their experience working together over the past 12 months.
Through the survey, nominees were scored across key operational categories including business development, budgeting approach, contract language, payment process, communication, efficient start-up, support for research participants from all communities, and effective use of technology. Medpace was selected as the CRO winner based on our overall performance rankings from this extensive community assessment.
“Medpace is thrilled to receive the 2025 Eagle Award. This recognition reflects our commitment to building exceptional partnerships with sites around the world. We would like to express our gratitude to the sites who play an essential role in effective clinical development, helping us bring new and innovative therapies to patients in need.”
– Gina Leisring, MPH, Sr. Vice-President, Clinical Monitoring at Medpace
Our Commitment to Building Strong Site Relationships
This recognition affirms our commitment to:
- Effective collaboration by establishing and maintaining open and responsive communication with sites.
- Operational excellence through the ability to streamline processes to reduce burden on sites.
- Patient-centered focus through ensuring trials remain accessible and meaningful for participants.
- Innovation using technology and integrated solutions to support efficiency and data quality.
Looking Ahead
We are grateful to SCRS and to the participating sites for this recognition. As we look to the future, Medpace will continue its focus on strengthening site relationships, enhancing collaboration, and working together to accelerate the development of safe and effective medical therapeutics.
About the Society for Clinical Research Sites (SCRS)
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 12,000+ sites in 75+ countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship and connection.